| scholarly article | Q13442814 |
| P2093 | author name string | Meenakshi Sharma | |
| Abraham Kovoor | |||
| Jeremy Celver | |||
| P2860 | cites work | Dopamine receptors: from structure to function | Q24336139 |
| Type 5 G protein beta subunit (Gbeta5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchors | Q24606708 | ||
| RGS9-2: probing an intracellular modulator of behavior as a drug target | Q24632848 | ||
| The R7 RGS protein family: multi-subunit regulators of neuronal G protein signaling | Q24643521 | ||
| Motor coordination deficits in mice lacking RGS9 | Q24648527 | ||
| Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5 | Q24670878 | ||
| Protein quality control in the ER: the recognition of misfolded proteins | Q37719977 | ||
| Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: proteins interacting with the third cytoplasmic loop of dopamine D2 and D3 receptors | Q37780639 | ||
| RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors | Q39703192 | ||
| Distribution of RGS9-2 in neurons of the mouse striatum. | Q40322043 | ||
| Morphine activates opioid receptors without causing their rapid internalization | Q41175884 | ||
| Effects of ionic and nonionic detergents on antigen-antibody reactions | Q41331131 | ||
| A fifth member of the mammalian G-protein beta-subunit family. Expression in brain and activation of the beta 2 isotype of phospholipase C. | Q41443050 | ||
| Co-expression of Gbeta5 enhances the function of two Ggamma subunit-like domain-containing regulators of G protein signaling proteins. | Q41716772 | ||
| RGS9 modulates dopamine signaling in the basal ganglia | Q42443389 | ||
| Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells | Q43242377 | ||
| RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. | Q46832204 | ||
| Expression and localization of RGS9-2/G 5/R7BP complex in vivo is set by dynamic control of its constitutive degradation by cellular cysteine proteases. | Q46840630 | ||
| Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain | Q48264084 | ||
| Quantitative analysis of the dopamine D4 receptor in the mouse brain | Q73392642 | ||
| Mutational analysis of the Asn residue essential for RGS protein binding to G-proteins | Q74326003 | ||
| DEP domains: More than just membrane anchors | Q79163974 | ||
| R7BP, a novel neuronal protein interacting with RGS proteins of the R7 family | Q81230034 | ||
| Structure of RGS4 bound to AlF4--activated G(i alpha1): stabilization of the transition state for GTP hydrolysis | Q27736041 | ||
| DEP-domain-mediated regulation of GPCR signaling responses. | Q27930240 | ||
| Lipid rafts and signal transduction | Q28131735 | ||
| Structure, alternative splicing, and expression of the human RGS9 gene | Q28138018 | ||
| Modulation of the affinity and selectivity of RGS protein interaction with G alpha subunits by a conserved asparagine/serine residue | Q28138422 | ||
| GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins | Q28145018 | ||
| Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain | Q28250219 | ||
| A novel form of the G protein β Subunit Gβ5 is specifically expressed in the vertebrate retina | Q28296250 | ||
| Mechanism of RGS4, a GTPase-activating protein for G protein alpha subunits | Q28574902 | ||
| RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons | Q28578625 | ||
| Brain-specific RGS9-2 is localized to the nucleus via its unique proline-rich domain | Q28580061 | ||
| Brain-specific regulator of G-protein signaling 9-2 selectively interacts with alpha-actinin-2 to regulate calcium-dependent inactivation of NMDA receptors | Q28580254 | ||
| Lipid rafts as a membrane-organizing principle | Q29615727 | ||
| Mammalian RGS proteins: multifunctional regulators of cellular signalling. | Q30354302 | ||
| Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene | Q30653116 | ||
| Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes | Q31520490 | ||
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? | Q33211909 | ||
| Proteomic identification of Hsc70 as a mediator of RGS9-2 degradation by in vivo interactome analysis | Q33932130 | ||
| Lipid rafts: elusive or illusive? | Q33973937 | ||
| Opioid receptors | Q34326054 | ||
| Dopamine receptor signaling | Q34364279 | ||
| D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. | Q34397299 | ||
| Psychosis pathways converge via D2high dopamine receptors | Q34540180 | ||
| Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default | Q34990345 | ||
| A novel kind of G protein heterodimer: the G beta5-RGS complex | Q35140422 | ||
| Understanding antipsychotic "atypicality": a clinical and pharmacological moving target | Q35200831 | ||
| Lipid rafts: heterogeneity on the high seas | Q35602692 | ||
| The dopamine D2 receptor: new surprises from an old friend | Q36213277 | ||
| Lipid rafts, detergent-resistant membranes, and raft targeting signals | Q36659985 | ||
| Organization of the functions and components of the endoplasmic reticulum | Q36700292 | ||
| A proteomic approach to receptor signaling: molecular mechanisms and therapeutic implications derived from discovery of the dopamine D2 receptor signalplex. | Q36896270 | ||
| G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. | Q37168203 | ||
| D2 receptor partial agonists: treatment of CNS disorders of dopamine function | Q37239954 | ||
| Domains in biological membranes | Q37562159 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 56-69 | |
| P577 | publication date | 2011-11-24 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions | |
| P478 | volume | 120 |
| Q30409324 | Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease |
| Q30451613 | D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms |
| Q33854287 | Desensitized D2 autoreceptors are resistant to trafficking |
| Q28542580 | G protein beta 5 is targeted to D2-dopamine receptor-containing biochemical compartments and blocks dopamine-dependent receptor internalization |
| Q35117457 | Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease |
| Q36812337 | Plasma membrane compartmentalization of D2 dopamine receptors |
| Q60954719 | RGS9-2 rescues dopamine D2 receptor levels and signaling in dystonia mouse models |
| Q90322691 | Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression |
| Q28547376 | Role for Rab10 in Methamphetamine-Induced Behavior |
Search more.